CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy

Immunotherapy has become a prominent strategy for the treatment of cancer. A method that improves the immune system’s ability to attack a tumor (Enhances antigen binding). Targeted killing of malignant cells by adoptive transfer of chimeric antigen receptor (CAR) T cells is a promising immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shademan, Behrouz, Karamad, Vahidreza, Nourazarian, Alireza, Avcı, Cigir Biray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348524/
https://www.ncbi.nlm.nih.gov/pubmed/35935042
http://dx.doi.org/10.34172/apb.2022.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348524/
https://www.ncbi.nlm.nih.gov/pubmed/35935042
http://dx.doi.org/10.34172/apb.2022.051

Ejemplares similares